AI Article Synopsis

  • This paper examines recent advancements and uses of silicone in ophthalmology, particularly focusing on intraocular lenses (IOLs) and their properties.
  • It highlights the need for better methods to assess the mechanical and in vivo performance of silicone IOLs to ensure their safety and long-term effectiveness.
  • The review discusses innovations in surface modifications and nanotechnology to enhance IOLs' biocompatibility and therapeutic functions, although more clinical trials are needed to bring these technologies into practice.

Article Abstract

This paper reviews the latest trends and applications of silicone in ophthalmology, especially related to intraocular lenses (IOLs). Silicone, or siloxane elastomer, as a synthetic polymer, has excellent biocompatibility, high chemical inertness, and hydrophobicity, enabling wide biomedical applications. The physicochemical properties of silicone are reviewed. A review of methods for mechanical and in vivo characterization of IOLs is presented as a prospective research area, since there are only a few available technologies, even though these properties are vital to ensure medical safety and suitability for clinical use, especially if long-term function is considered. IOLs represent permanent implants to replace the natural lens or for correcting vision, with the first commercial foldable lens made of silicone. Biological aspects of posterior capsular opacification have been reviewed, including the effects of the implanted silicone IOL. However, certain issues with silicone IOLs are still challenging and some conditions can prevent its application in all patients. The latest trends in nanotechnology solutions have been reviewed. Surface modifications of silicone IOLs are an efficient approach to further improve biocompatibility or to enable drug-eluting function. Different surface modifications, including coatings, can provide long-term treatments for various medical conditions or medical diagnoses through the incorporation of sensory functions. It is essential that IOL optical characteristics remain unchanged in case of drug incorporation and the application of nanoparticles can enable it. However, clinical trials related to these advanced technologies are still missing, thus preventing their clinical applications at this moment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11278226PMC
http://dx.doi.org/10.3390/ma17143454DOI Listing

Publication Analysis

Top Keywords

silicone ophthalmology
8
latest trends
8
silicone iols
8
surface modifications
8
silicone
7
iols
5
application silicone
4
ophthalmology review
4
review paper
4
paper reviews
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!